Evotec
Company Snapshot
Founded: 1993
Entity Type: Public
Employees: 5061
Region: U.S.
Revenue: $845.2 Millions
Revenue Year: 2023
Headquarter: Hamburg, Germany
Key Geographics: U.S., Germany, France, U.K., Switzerland, Rest of the World
Corporate Address: Essener Bogen 7 22419 Hamburg, Germany Tel. +49-40-560-81-0 www.evotec.com
Company Overview
Evotec SE operates as a drug discovery alliance and development partnership firm, focusing on discovering and developing small molecule drugs across diverse therapeutic areas. The company offers various drug discovery services, including target identification and validation, sample management, hit identification, in vitro pharmacology services, integrated CMC (Chemistry, Manufacturing, and Control), and proteomics services.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Company's Business Segments
- EVT Execute : Fee-for-service, FTE rate-based arrangements
- EVT Innovate : Evotec’s internal R&D activities, Services, and partnerships originate from these R&D activities
Applications/End User Industries
- Biotech
- Pharma
- Non-Profit organizations
BCC Research Beacon 